DrugCite
Search

LIORESAL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Lioresal Adverse Events Reported to the FDA Over Time

How are Lioresal adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lioresal, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lioresal is flagged as the suspect drug causing the adverse event.

Most Common Lioresal Adverse Events Reported to the FDA

What are the most common Lioresal adverse events reported to the FDA?

Drug Ineffective
2392 (7.03%)
Hypertonia
2071 (6.09%)
Muscle Spasticity
1255 (3.69%)
Pain
868 (2.55%)
Drug Withdrawal Syndrome
798 (2.35%)
Overdose
724 (2.13%)
Withdrawal Syndrome
579 (1.7%)
Pruritus
544 (1.6%)
Somnolence
474 (1.39%)
Hypotonia
457 (1.34%)
Muscle Spasms
452 (1.33%)
Show More Show More
Pyrexia
445 (1.31%)
Medical Device Complication
432 (1.27%)
Infection
425 (1.25%)
Condition Aggravated
404 (1.19%)
Death
400 (1.18%)
Therapeutic Response Decreased
358 (1.05%)
Nausea
352 (1.04%)
Convulsion
338 (.99%)
Headache
330 (.97%)
Vomiting
291 (.86%)
Underdose
278 (.82%)
Device Malfunction
230 (.68%)
Paraesthesia
229 (.67%)
Hyperhidrosis
220 (.65%)
Hospitalisation
219 (.64%)
Intracranial Hypotension
196 (.58%)
Asthenia
188 (.55%)
Implant Site Infection
185 (.54%)
Device Related Infection
181 (.53%)
Implant Site Effusion
179 (.53%)
Confusional State
177 (.52%)
Tremor
172 (.51%)
Gait Disturbance
171 (.5%)
Hypotension
171 (.5%)
Insomnia
168 (.49%)
Malaise
165 (.49%)
Urinary Tract Infection
165 (.49%)
Catheter Related Complication
164 (.48%)
Agitation
162 (.48%)
Muscle Tightness
154 (.45%)
Therapy Cessation
149 (.44%)
Coma
147 (.43%)
Pneumonia
145 (.43%)
Device Failure
142 (.42%)
Fall
141 (.41%)
Dizziness
137 (.4%)
Musculoskeletal Stiffness
136 (.4%)
Dyspnoea
134 (.39%)
Lethargy
134 (.39%)
No Therapeutic Response
134 (.39%)
Device Dislocation
131 (.39%)
Device Breakage
128 (.38%)
Meningitis
128 (.38%)
Mental Status Changes
124 (.36%)
Drug Effect Decreased
118 (.35%)
Irritability
117 (.34%)
Tachycardia
116 (.34%)
Unresponsive To Stimuli
115 (.34%)
Hallucination
113 (.33%)
Wound Dehiscence
112 (.33%)
Muscle Rigidity
107 (.31%)
Device Connection Issue
104 (.31%)
Hypertension
104 (.31%)
Muscular Weakness
104 (.31%)
Constipation
103 (.3%)
Staphylococcal Infection
103 (.3%)
Injury
102 (.3%)
Sepsis
102 (.3%)
Seroma
99 (.29%)
Back Pain
98 (.29%)
Loss Of Consciousness
95 (.28%)
Anxiety
91 (.27%)
Respiratory Disorder
91 (.27%)
Device Leakage
90 (.26%)
Urinary Retention
88 (.26%)
Depressed Level Of Consciousness
82 (.24%)
Clonus
81 (.24%)
Device Occlusion
81 (.24%)
Hypoaesthesia
79 (.23%)
Cognitive Disorder
77 (.23%)
Oedema Peripheral
77 (.23%)
Feeling Abnormal
76 (.22%)
Implant Site Swelling
76 (.22%)
Respiratory Depression
73 (.21%)
Speech Disorder
73 (.21%)
Abdominal Pain
71 (.21%)
Respiratory Failure
68 (.2%)
Dystonia
67 (.2%)
Burning Sensation
65 (.19%)
Abasia
64 (.19%)
Chills
62 (.18%)
Depression
62 (.18%)
Pain In Extremity
62 (.18%)
Fatigue
61 (.18%)
Bradycardia
60 (.18%)
Erythema
60 (.18%)
Incorrect Dose Administered
60 (.18%)
Diarrhoea
58 (.17%)
Dyskinesia
57 (.17%)
Dysphagia
57 (.17%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Lioresal, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lioresal is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lioresal

What are the most common Lioresal adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lioresal, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lioresal is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Lioresal According to Those Reporting Adverse Events

Why are people taking Lioresal, according to those reporting adverse events to the FDA?

Muscle Spasticity
9541
Cerebral Palsy
126
Multiple Sclerosis
90
Muscle Spasms
51
Drug Use For Unknown Indication
49
Pain
40
Show More Show More
Brain Injury
38
Spinal Cord Injury
35
Product Used For Unknown Indication
24
Cerebrovascular Accident
21
Head Injury
20
Spinal Cord Disorder
14
Muscle Contracture
14
Hiccups
13
Relapsing-remitting Multiple Sclero...
11
Neuralgia
11
Quadriplegia
10
Spastic Paralysis
9
Muscle Relaxant Therapy
8
Musculoskeletal Stiffness
8
Dystonia
7
Analgesic Therapy
7
Multiple Sclerosis Relapse
7
Paraplegia
7
Trigeminal Neuralgia
7
Pain In Extremity
6
Hypertonia
6
Migraine
6
Paraparesis
5
Post Laminectomy Syndrome
5
Unevaluable Event
5
Convulsion
4
Amyotrophy
4
Quadriparesis
4
Ataxia
4
Motor Dysfunction
4
Osteoarthritis
3
Muscle Disorder
3
Spastic Paraplegia
3
Stiff Person Syndrome
3
Hypotonia
3
Alcoholism
3
Cervicobrachial Syndrome
3
Hemiplegia
3
Medication Error
3
Pyramidal Tract Syndrome
3
Infantile Spasms
3
Prophylaxis
3
Spinal Laminectomy
2
Delirium Tremens
2
Nystagmus
2

Drug Labels

LabelLabelerEffective
LioresalMedtronic Neuromodulation14-MAR-13

Lioresal Case Reports

What Lioresal safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Lioresal. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Lioresal.